Stepan Company

NYSE:SCL Stock Report

Market Cap: US$1.2b

Stepan Future Growth

Future criteria checks 3/6

Stepan is forecast to grow earnings and revenue by 174.6% and 4.7% per annum respectively while EPS is expected to grow by 174.4% per annum.

Key information

174.6%

Earnings growth rate

174.44%

EPS growth rate

Chemicals earnings growth17.1%
Revenue growth rate4.7%
Future return on equityn/a
Analyst coverage

Low

Last updated07 May 2026

Recent future growth updates

Analysis Article May 02

Results: Stepan Company Exceeded Expectations And The Consensus Has Updated Its Estimates

A week ago, Stepan Company ( NYSE:SCL ) came out with a strong set of first-quarter numbers that could potentially lead...

Recent updates

Narrative Update Apr 28

SCL: Stable Margins And Buybacks Will Support Long-Term Dividend Upside

Analysts kept their fair value estimate steady at $75, with only marginal tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions. This indicates a largely unchanged view of Stepan's longer term potential.
Narrative Update Apr 12

SCL: Stable Margins And Buyback Completion Will Support Long-Term Dividend Upside

Analysts have nudged their Stepan price target slightly higher to $75.00, with modest tweaks to the discount rate and P/E assumptions supporting this updated view. What's in the News For the three months ended December 31, 2025, Stepan Company reported unaudited goodwill impairment of $6,245,000, which directly affects reported earnings quality for that period (Key Developments).
Seeking Alpha Mar 28

Stepan Company: The Ride Higher Isn't Over Yet

Summary Stepan Company (SCL) is reaffirmed as a 'buy' due to compelling valuation and significant cost-saving initiatives. SCL's Project Catalyst targets $100M in pre-tax savings over two years, with 60% expected in the current year. Despite mixed profitability and cash flow, SCL remains attractively priced versus peers, especially on cash flow metrics. Even if cost savings underdeliver, current valuation provides downside protection and long-term upside potential. Read the full article on Seeking Alpha
Narrative Update Mar 28

SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside

Analysts have maintained their Stepan fair value estimate at $75.00, making only small adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions. This signals that their overall view on the stock’s longer-term potential remains largely unchanged.
Narrative Update Mar 14

SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside

Analysts have modestly revised their price outlook for Stepan, keeping fair value around $75.00 while making small tweaks to the discount rate and projected P/E. This reflects updated assumptions about the risk profile and valuation multiples rather than a shift in the underlying growth or margin view.
Narrative Update Feb 27

SCL: Higher Future P/E Assumptions Will Support Long-Term Dividend Upside

Analysts have adjusted their Stepan price target to $75.00, with the change tied to updated views on discount rate, revenue growth, profit margin, and a higher assumed future P/E multiple. What's in the News Stepan Company reported an unaudited goodwill impairment of $6,245,000 for the three months ended December 31, 2025.
Narrative Update Feb 11

SCL: Refined Discount Rate Assumptions Will Support Long-Term Dividend Upside

Analysts have kept their Stepan price target steady at $75.00, citing only slight tweaks to assumptions like discount rate, revenue growth, profit margin, and future P/E that were not material enough to change their overall valuation view. Valuation Changes Fair Value: Steady at $75.00, indicating no change in the analysts' central valuation estimate.
Analysis Article Feb 04

Why Investors Shouldn't Be Surprised By Stepan Company's (NYSE:SCL) 26% Share Price Surge

Despite an already strong run, Stepan Company ( NYSE:SCL ) shares have been powering on, with a gain of 26% in the last...
Narrative Update Jan 27

SCL: Higher Discount Rate Will Set Up Attractive Long-Term Dividend Returns

Analysts now estimate Stepan's fair value at US$75.00, reduced from US$82.21. This change reflects updated assumptions regarding a higher discount rate, revised profit margin expectations, a slightly higher revenue growth outlook, and a lower future P/E multiple.
Analysis Article Jan 08

Stepan (NYSE:SCL) May Have Issues Allocating Its Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
Analysis Article Dec 12

Why Stepan Company (NYSE:SCL) Could Be Worth Watching

Stepan Company ( NYSE:SCL ), is not the largest company out there, but it saw a double-digit share price rise of over...
Analysis Article Nov 04

Stepan (NYSE:SCL) Will Pay A Larger Dividend Than Last Year At $0.395

Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...
Analysis Article Sep 04

Here's What's Concerning About Stepan's (NYSE:SCL) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Analysis Article Jul 31

Is It Time To Consider Buying Stepan Company (NYSE:SCL)?

While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...
Analysis Article Jun 10

Earnings Tell The Story For Stepan Company (NYSE:SCL)

Stepan Company's ( NYSE:SCL ) price-to-earnings (or "P/E") ratio of 22.5x might make it look like a sell right now...
Analysis Article May 02

Results: Stepan Company Exceeded Expectations And The Consensus Has Updated Its Estimates

A week ago, Stepan Company ( NYSE:SCL ) came out with a strong set of first-quarter numbers that could potentially lead...
Seeking Alpha Apr 20

Stepan Company's Plunge Offers Investors A Chance To Clean Up

Summary Markets are inefficient short-term, creating opportunities for logical, value-oriented investors; Stepan Company is now a ‘buy’ due to recent price drops and management's positive outlook. Despite a 6% revenue drop in 2024, Stepan Company improved net income and EBITDA, driven by cost-cutting measures and productivity improvements. Management is optimistic about 2025, expecting volume growth, margin improvement, and positive free cash flow, targeting high-margin, growth-oriented markets. Analysts forecast revenue and earnings growth for Q1 2025; shares are attractively priced compared to peers, justifying an upgrade to a ‘buy’ rating. Read the full article on Seeking Alpha
Analysis Article Apr 16

Should You Investigate Stepan Company (NYSE:SCL) At US$47.60?

While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...
Seeking Alpha Feb 04

Stepan Company: A 'Moderate Buy' Despite A High Valuation

Summary Stepan Company, a specialty chemicals manufacturer, excels in operational efficiency and dividend growth, making it a stable investment despite current valuations. Q3 FY24 financials show margin expansion and significant net income growth, despite a 3% revenue decline, highlighting fiscal discipline. Trading at a forward P/E of 17.3x for 2025, Stepan's stock has a potential 26% upside, making it a promising investment opportunity. I am an investment analyst with a focus on income generation. Read the full article on Seeking Alpha
Analysis Article Jan 18

Shareholders Should Be Pleased With Stepan Company's (NYSE:SCL) Price

With a price-to-earnings (or "P/E") ratio of 31.4x Stepan Company ( NYSE:SCL ) may be sending very bearish signals at...
Analysis Article Nov 26

These 4 Measures Indicate That Stepan (NYSE:SCL) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Nov 02

Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's

The board of Stepan Company ( NYSE:SCL ) has announced that the dividend on 13th of December will be increased to...
Seeking Alpha Oct 30

Stepan Company: Not A Great Performance, But Good Value

Summary Stepan Company, despite underperformance and volatility, has long-term upside due to its unique position in the specialty chemicals market, particularly surfactants. The company's fundamentals have improved with reduced CapEx and positive FCF, but current earnings and macro pressures persist. SCL's growth potential is tied to the surfactant segment and market diversification, though the timing of earnings recovery remains uncertain. I rate Stepan as a "Buy" with a $90 PT, but caution that there are superior investments in the chemicals sector with better returns. Read the full article on Seeking Alpha
User avatar
New Narrative Sep 24

Calculated Supply Chain And Market Expansion Drive Robust Growth And Margin Improvement

Operational cost reductions and workforce productivity improvements aim to positively impact net margins.
Analysis Article Aug 30

Some Investors May Be Worried About Stepan's (NYSE:SCL) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
Analysis Article Aug 17

Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Seeking Alpha Jul 28

Stepan Company Is Making Great Progress

Summary Stepan Company faced declining revenue, profits, and cash flows due to weak demand and inventory destocking, leading to a 'hold' rating. Despite a difficult 2023, the company showed improvements in cash flows and margins in the first quarter of 2024. Analysts expect revenue and earnings per share to improve in the second quarter of 2024, but shares are not yet attractively priced for an upgrade. Read the full article on Seeking Alpha
Analysis Article Jul 24

When Should You Buy Stepan Company (NYSE:SCL)?

Stepan Company ( NYSE:SCL ), is not the largest company out there, but it saw a decent share price growth of 11% on the...

Earnings and Revenue Growth Forecasts

NYSE:SCL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20282,738N/A139N/A1
12/31/20272,66673132N/A2
12/31/20262,512055N/A2
3/31/20262,343-1437158N/A
12/31/20252,3324725148N/A
9/30/20252,3044532156N/A
6/30/20252,26058-12109N/A
3/31/20252,222562127N/A
12/31/20242,1805039162N/A
9/30/20242,1874629163N/A
6/30/20242,2023550210N/A
3/31/20242,2263890288N/A
12/31/20232,32640-85175N/A
9/30/20232,42152-118192N/A
6/30/20232,57879-174158N/A
3/31/20232,749118-224110N/A
12/31/20222,773147-141161N/A
9/30/20222,756153-155126N/A
6/30/20222,640151-16386N/A
3/31/20222,484142-15463N/A
12/31/20212,346138-12672N/A
9/30/20212,231151-49115N/A
6/30/20212,09214752201N/A
3/31/20211,95814096230N/A
12/31/20201,870127107235N/A
9/30/20201,820118106227N/A
6/30/20201,80711181198N/A
3/31/20201,82010692208N/A
12/31/20191,859103N/A218N/A
9/30/20191,880105N/A208N/A
6/30/20191,937101N/A196N/A
3/31/20191,984104N/A175N/A
12/31/20181,994111N/A171N/A
9/30/20182,00197N/A170N/A
6/30/20181,98197N/A192N/A
3/31/20181,95692N/A197N/A
12/31/20171,925101N/A199N/A
9/30/20171,87290N/A217N/A
6/30/20171,82990N/A197N/A
3/31/20171,78990N/A217N/A
12/31/20161,76686N/A212N/A
9/30/20161,76591N/A180N/A
6/30/20161,76494N/A182N/A
3/31/20161,76283N/A148N/A
12/31/20151,77676N/A184N/A
9/30/20151,81169N/A161N/A
6/30/20151,85958N/A145N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SCL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.5%).

Earnings vs Market: SCL is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: SCL is expected to become profitable in the next 3 years.

Revenue vs Market: SCL's revenue (4.7% per year) is forecast to grow slower than the US market (11.6% per year).

High Growth Revenue: SCL's revenue (4.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SCL's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/11 14:21
End of Day Share Price 2026/05/11 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Stepan Company is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael HarrisonSeaport Research Partners
Daniel RizzoSidoti & Company, LLC
Vincent AndersonStifel, Equities Research